141 related articles for article (PubMed ID: 37232855)
1. Efficacy of Carbapenems Compared With Noncarbapenem Broad-Spectrum Beta-Lactam Antibiotics as Initial Antibiotic Therapy Against Sepsis: A Nationwide Observational Study.
Umemura Y; Yamakawa K; Tanaka Y; Yoshimura J; Ogura H; Fujimi S
Crit Care Med; 2023 Sep; 51(9):1210-1221. PubMed ID: 37232855
[TBL] [Abstract][Full Text] [Related]
2. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
Micek ST; Welch EC; Khan J; Pervez M; Doherty JA; Reichley RM; Kollef MH
Antimicrob Agents Chemother; 2010 May; 54(5):1742-8. PubMed ID: 20160050
[TBL] [Abstract][Full Text] [Related]
3. Empirical carbapenems or piperacillin/tazobactam for infections in intensive care: An international retrospective cohort study.
Meier N; Munch MW; Granholm A; Perner A; Hertz FB; Venkatesh B; Hammond NE; Li Q; De Bus L; De Waele J; Kauzonas E; Sjövall F; Møller MH; Helleberg M
Acta Anaesthesiol Scand; 2024 Jul; 68(6):821-829. PubMed ID: 38549422
[TBL] [Abstract][Full Text] [Related]
4. Superinfection rate among the patients treated with carbapenem versus piperacillin/tazobactam: Retrospective observational study.
Al Muqati H; Al Turaiki A; Al Dhahri F; Al Enazi H; Althemery A
J Infect Public Health; 2021 Mar; 14(3):306-310. PubMed ID: 33618274
[TBL] [Abstract][Full Text] [Related]
5. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
Tamma PD; Han JH; Rock C; Harris AD; Lautenbach E; Hsu AJ; Avdic E; Cosgrove SE;
Clin Infect Dis; 2015 May; 60(9):1319-25. PubMed ID: 25586681
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems.
Tan SH; Ng TM; Chew KL; Yong J; Wu JE; Yap MY; Heng ST; Ng WHW; Wan S; Cheok SJH; Tambyah PA; Lye DC
Int J Antimicrob Agents; 2020 Feb; 55(2):105860. PubMed ID: 31841674
[TBL] [Abstract][Full Text] [Related]
7. Piperacillin/tazobactam vs carbapenems for patients with bacterial infection: Protocol for a systematic review.
Petersen MW; Perner A; Sjövall F; Jonsson AB; Steensen M; Andersen JS; Achiam MP; Frimodt-Møller N; Møller MH
Acta Anaesthesiol Scand; 2019 Aug; 63(7):973-978. PubMed ID: 31020663
[TBL] [Abstract][Full Text] [Related]
8. Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.
Ng TM; Khong WX; Harris PN; De PP; Chow A; Tambyah PA; Lye DC
PLoS One; 2016; 11(4):e0153696. PubMed ID: 27104951
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Duration and Empiric Antibiotic Choice of Post-Operative Treatment in Abdominal Sepsis.
Surat G; Meyer-Sautter P; Rüsch J; Braun-Feldweg J; Germer CT; Lock JF
Surg Infect (Larchmt); 2022 Jun; 23(5):444-450. PubMed ID: 35532964
[No Abstract] [Full Text] [Related]
10. Appropriate non-carbapenems are not inferior to carbapenems as initial empirical therapy for bacteremia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a propensity score weighted multicenter cohort study.
Ko JH; Lee NR; Joo EJ; Moon SY; Choi JK; Park DA; Peck KR
Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):305-311. PubMed ID: 29177611
[TBL] [Abstract][Full Text] [Related]
11. A retrospective observational study of antibiotics treatment for sepsis using a nationwide claim database in Japan.
Igari H; Yamagishi K; Yamazaki S; Yahaba M; Takayanagi S; Kawasakis Y; Taniguchi T
J Infect Chemother; 2020 Nov; 26(11):1111-1115. PubMed ID: 32792247
[TBL] [Abstract][Full Text] [Related]
12. Evaluating vancomycin and piperacillin-tazobactam in ED patients with severe sepsis and septic shock.
Le C; Chu F; Dunlay R; Villar J; Fedullo P; Wardi G
Am J Emerg Med; 2018 Aug; 36(8):1380-1385. PubMed ID: 29321120
[TBL] [Abstract][Full Text] [Related]
13. Ceftriaxone versus tazobactam/piperacillin and carbapenems in the treatment of aspiration pneumonia: A propensity score matching analysis.
Asai N; Suematsu H; Ohashi W; Shibata Y; Sakanashi D; Kato H; Shiota A; Watanabe H; Hagihara M; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2021 Oct; 27(10):1465-1470. PubMed ID: 34158237
[TBL] [Abstract][Full Text] [Related]
14. Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS).
Russell NJ; Stöhr W; Plakkal N; Cook A; Berkley JA; Adhisivam B; Agarwal R; Ahmed NU; Balasegaram M; Ballot D; Bekker A; Berezin EN; Bilardi D; Boonkasidecha S; Carvalheiro CG; Chami N; Chaurasia S; Chiurchiu S; Colas VRF; Cousens S; Cressey TR; de Assis ACD; Dien TM; Ding Y; Dung NT; Dong H; Dramowski A; Ds M; Dudeja A; Feng J; Glupczynski Y; Goel S; Goossens H; Hao DTH; Khan MI; Huertas TM; Islam MS; Jarovsky D; Khavessian N; Khorana M; Kontou A; Kostyanev T; Laoyookhon P; Lochindarat S; Larsson M; Luca M; Malhotra-Kumar S; Mondal N; Mundhra N; Musoke P; Mussi-Pinhata MM; Nanavati R; Nakwa F; Nangia S; Nankunda J; Nardone A; Nyaoke B; Obiero CW; Owor M; Ping W; Preedisripipat K; Qazi S; Qi L; Ramdin T; Riddell A; Romani L; Roysuwan P; Saggers R; Roilides E; Saha SK; Sarafidis K; Tusubira V; Thomas R; Velaphi S; Vilken T; Wang X; Wang Y; Yang Y; Zunjie L; Ellis S; Bielicki JA; Walker AS; Heath PT; Sharland M
PLoS Med; 2023 Jun; 20(6):e1004179. PubMed ID: 37289666
[TBL] [Abstract][Full Text] [Related]
15. Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing
Benanti GE; Brown ART; Shigle TL; Tarrand JJ; Bhatti MM; McDaneld PM; Shelburne SA; Aitken SL
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509935
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Bacteremia Caused by
Drozdinsky G; Neuberger A; Rakedzon S; Nelgas O; Cohen Y; Rudich N; Mushinsky L; Ben-Zvi H; Paul M; Yahav D
Microb Drug Resist; 2021 Mar; 27(3):410-414. PubMed ID: 32808858
[No Abstract] [Full Text] [Related]
17. Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study.
Babich T; Naucler P; Valik JK; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Abdel Fattah M; Haquin J; Macgowan A; Grier S; Gibbs J; Chazan B; Yanovskay A; Ben Ami R; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Mauer S; Rodriguez-Bano J; Morales I; Oliver A; Ruiz De Gopegui E; Cano A; Machuca I; Gozalo-Marguello M; Martinez Martinez L; Gonzalez-Barbera EM; Alfaro IG; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstein Y; Leibovici L; Yahav D
Clin Infect Dis; 2020 May; 70(11):2270-2280. PubMed ID: 31323088
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Treatment Outcome of Piperacillin-Tazobactam versus Carbapenems for Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli in Areas with Low Frequency of Coproduction of OXA-1: a Preliminary Analysis.
Hoashi K; Hayama B; Suzuki M; Sakurai A; Takehana K; Enokida T; Takeda K; Ohkushi D; Doi Y; Harada S
Microbiol Spectr; 2022 Aug; 10(4):e0220622. PubMed ID: 35916524
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study.
Maillard A; Delory T; Bernier J; Villa A; Chaibi K; Escaut L; Contejean A; Bercot B; Robert J; El Alaoui F; Tankovic J; Poupet H; Cuzon G; Lafaurie M; Surgers L; Joseph A; Paccoud O; Molina JM; Bleibtreu A;
Int J Antimicrob Agents; 2023 Jul; 62(1):106809. PubMed ID: 37028731
[TBL] [Abstract][Full Text] [Related]
20. Aminoglycoside versus carbapenem or piperacillin/tazobactam treatment for bloodstream infections of urinary source caused by Gram-negative ESBL-producing Enterobacteriaceae.
Zohar I; Schwartz O; Yossepowitch O; David SSB; Maor Y
J Antimicrob Chemother; 2020 Feb; 75(2):458-465. PubMed ID: 31691817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
